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Background
The major peanut allergens Arah1, Arah2, and Arah3
are considered the more important sensitizers in peanut
allergy, although the lipid transfer protein (LTP) Arah9
has been shown relevant in Mediterranean areas. We
evaluated the basophil activation response (BAT) to dif-
ferent peanut allergens and the peach LTP Prup3 in
patients with peanut allergy.
Methods
We included 60 subjects in different groups: Group 1,
peanut and peach allergy; Group 2, peanut allergy and
good tolerance to peach; Group 3, peach allergy and
good tolerance to peanut; Group 4, good tolerance to
peach and peanut. The diagnostic was performed by
clinical history, skin prick test and/or double blind pla-
cebo controlled food challenge. BAT to Arah1, Arah2,
Arah3, Arah6, rArah9 and rPrup3 was done using anti-
IgE and CD63 and cells analyzed in a FACSCalibur flow
cytometer.
Results
Comparisons of BAT results between peanut allergic
patients (Group 1 and 2) and controls (Group 4)
showed increased basophil activation in Group 1 with
Arah2 (p=0.031) and Prup3 (p=0.009) whereas Group 2
had an increase with Arah1 (p=0.016), Arah2 (p=0.001)
and Arah9 (p=0.016), but not with Prup3. Comparisons
with subjects allergic to peach with good tolerance to
peanut (Group 3) showed a BAT increase only with
Arah2 (p=0.009) in Group 2. Finally, the comparisons
between groups with good tolerance to peanut (Groups
3 and 4) showed significant differences for peach allergic
patients with Arah9 (p=0.004) and Prup3 (p=0.008).
Conclusion
The peanut allergen Arah2 is the best to discriminate
peanut allergy in a Mediterranean population where
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